Investor Alert

New York Markets Open in:

Market Pulse Archives

Oct. 21, 2021, 7:05 a.m. EDT

Quest Diagnostics net income falls; hikes 2021 outlook

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Quest Diagnostics Inc. (DGX)

or Cancel Already have a watchlist? Log In

By Steve Gelsi


Quest Diagnostics Inc. /zigman2/quotes/201001842/composite DGX +0.39% said Thursday its third-quarter net income fell to $505 million, or $4.02 a share, from $568 million, or $4.14 a share in the year-ago quarter. Adjusted earnings fell to $3.96 a share from $4.31 a share. Revenue at the medical testing company dropped to $2.774 billion from $2.786 billion. Analysts expected the company to earn $2.88 a share on revenue of $2.452 billion, according to a FactSet survey. Quest Diagnostics said it's lifting its 2021 profit target to a range of $13.50 to $13.90 a share, from its previous guidance of $11.65 to $12.35 share because of higher than expected COVID-19 testing volume. Analysts expected the company to earn $12.12 a share in 2021. Shares of Quest Diagnostics rose 3% in pre-market trades. As of Wednesday's close, the stock is up 23.2% so far this year, compared to a rise of 20.8% by the S&P 500.

$ 140.09
+0.55 +0.39%
Volume: 1.45M
May 24, 2022 4:03p
P/E Ratio
Dividend Yield
Market Cap
$16.38 billion
Rev. per Employee

Get news alerts on Quest Diagnostics Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.